This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
Clinical Summary

Face psoriasis linked to increased ESRD risk, but systemic treatment may help

Takeaway

  • Patients with psoriasis are at increased risk of end-stage renal disease (ESRD), although this association is not found in patients who received systemic treatment, according to a population study.

Key results

  • Psoriasis was associated with increased risk of ESRD in adjusted analysis (HR, 1.58; P<.001).
  • Psoriatic arthritis was associated with a further increased risk of ESRD in adjusted analysis (HR, 7.60; P<.001).
  • In subgroup, psoriasis was significantly associated with ESRD risk in patients who did not receive systemic treatment (HR, 1.60; P<.001) but not in patients who received systemic treatment (HR, 1.07; 95% CI, 0.80-1.41).
  • Patients treated with acitretin (Soriatane) had a reduced risk of ESRD (HR, 0.576; 95% CI, 0.385-0.863) compared with patients who did not receive systemic treatment.

Study design

  • 2,121,228 adult subjects, 530,307 with psoriasis, were analysed for ESRD risk.
  • Funding: National Research Foundation of the Republic of Korea.

Limitations

  • Observational study of large database.

References


YOU MAY ALSO LIKE